Pembrolizumab Plus Lenvatinib in Unresectable Cutaneous Angiosarcoma Patients
Abroad (travel likely)RecruitingPHASE2
Conditions
Angiosarcoma of Skin · Angiosarcoma Metastatic
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Cancer Center Hospital East, Kashiwa, Japan
University Hospital Kyoto Prefectural University of Medicine, Kyoto, Japan
Faculty of Medicine, University of Miyazaki Hospital, Miyazaki, Japan
Nagoya City University Hospital, Nagoya, Japan
Keio University Hospital, Tokyo, Japan
National Cancer Center Hospital, Tokyo, Japan